Sustained Weight Loss, Ongoing Reduction of Cardiovascular Risk Factors and Continued Glycemic Control at Two Years: Data from EnteroMedics'' vBloc DM2 Study Published in the Journal of Obesity Surgery
http://www.nasdaq.com/press-release/sustained...1027-00289